AN2 Therapeutics (ANTX) announced a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis. As part of this effort, the Gates Foundation will provide a third year of funding to support AN2’s work within the collaboration.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: